Skip to page content
Office of Workers' Compensation Programs

Division of Federal Employees' Compensation (DFEC)

Schedule II Drug Program Changes for FECA

On May 3, 2011, The Department of Labor (DOL) implemented a new policy for processing Schedule II drugs for claimants who are identified as recipients under the Federal Employees Compensation Act (FECA) Program. Patients who do not have a diagnosis of cancer as an accepted work-related medical condition and have not received a fentanyl prescription in the past six months will no longer be able to receive fentanyl prescriptions, except for Duragesic. Patients with a diagnosis of cancer as an accepted work-related medical condition will continue to be able to receive Schedule II medications, including fentanyl products, in the same manner as today. All Schedule 2 prescriptions continue to be subject to early refill limitation and days' supply limitations. This includes the requirement that a claimant use 75% of the previous fill before being allowed to receive another fill of the same Schedule 2 medication and that a Schedule II fill be limited to 30 days. Please contact the PBM call center @ 866-664-5581 with any questions about these changes.